The pharmaceutical companies which manufactured ranitidine-based products in the U.S. are legally responsible for exposing Zantac users to the risk of cancer through NDMA.
Because N-nitrosodimethylamine (NDMA) is reasonably anticipated to be a human carcinogen, according to the U.S. Environmental Protection Agency, manufacturers should have known that the organic compound is toxic.
Thus, it should have known that drugs containing ranitidine could cause cancer in humans and should not have used the agent in Zantac and its generics. By failing to ensure the safety of those taking their medication, they may be held financially liable for the damages, injuries, and deaths suffered by consumers.
At Atraxia Law, we know most people take medications to recover from an illness or help treat a condition. The last thing our clients expect is to wind up in a hospital or deal with serious complications due to the drug they thought would help them.
If you’ve been diagnosed with cancer after taking Zantac or generic ranitidine, you may be eligible to recover compensation for the physical, emotional, and financial harm that you have suffered.
If you took Zantac or any other ranitidine medications for an extended period of time and developed cancer, you may have a case against the drug manufacturer. You can join the class-action lawsuit, or you can file a separate claim alone.
For patients diagnosed with Zantac-related cancers, the following types of damages might apply:
If you lost a loved one due to a Zantac-related illness, you can file a wrongful death lawsuit to collect compensation for damages such as: